Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Moody Longevity Trial: Tirzepatide to Slow Biological Aging

NCT07220473 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT07220473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Moody Longevity Trial: Tirzepatide to Slow Biological Aging
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Phase 2
Overall status
Recruiting
Start date
February 27, 2026
Completion date
January 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, longevity 1